On account of the above, the aim of this study was to evaluate the expression of HIF-1α, GLUT1 and CAIX in peripheral blood samples taken from breast cancer patients as well as in samples of tumor tissue and peripheral blood from healthy donors. The gene discussed is SLC2A1; the disease is neoplasm.